E-LIB Suche - Ergebnisse für: Laetsch, Theodore W.

1

HGG-02. LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN P..:

Perreault, Sébastien ; Doz, François ; Deyell, Rebecca J...
Neuro-Oncology. 26 (2024) Supplement_4 - p. 0-0 , 2024

2

Establishing Costs for Commercial Chimeric Antigen Receptor..:

Satwani, Prakash ; Chao, Karen ; Lopez-Garcia, Maria...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S224-S225 , 2024

Link: https://doi.org/10.1016/..

3

Absolute neutrophil count clinical trial eligibility criter..:

Ruiz, Jenny ; Kelly, Rebecca K. ; Aplenc, Richard..
Pediatric Blood & Cancer. 71 (2024) 5 - p. , 2024

Link: https://doi.org/10.1002/..

4

Practice Preferences for Consolidative Hematopoietic Stem C..:

McNerney, Kevin O. ; Moskop, Amy ; Winestone, Lena E....
Transplantation and Cellular Therapy. 30 (2024) 1 - p. 75.e1-75.e11 , 2024

Link: https://doi.org/10.1016/..

5

Risk Factors for Hematotoxicity Following Tisagenlecleucel ..:

McNerney, Kevin Owen ; Fabrizio, Vanessa A. ; Talleur, Aimee C....
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S219-S220 , 2024

Link: https://doi.org/10.1016/..

6

INSPIRED Symposium Part 1: Clinical Variables Associated wi..:

Myers, Regina M. ; Jacoby, Elad ; Pulsipher, Michael A....
Transplantation and Cellular Therapy. 29 (2023) 10 - p. 598-607 , 2023

Link: https://doi.org/10.1016/..

7

Mediport Use As an Acceptable Standard for CAR T Cell Infus..:

Eylon, Maya ; Baggott, Christina ; Prabhu, Snehit...
Transplantation and Cellular Therapy. 29 (2023) 2 - p. S195-S196 , 2023

Link: https://doi.org/10.1016/..

8

Higher doses of tisagenlecleucel are associated with improv..:

Stefanski, Heather E. ; Eaton, Anne ; Baggott, Christina...
Blood Advances. 7 (2023) 4 - p. 541-548 , 2023

Link: https://doi.org/10.1182/..

9

Clinical Practice Patterns and Factors Driving Usage of Con..:

McNerney, Kevin O. ; Moskop, Amy ; Winestone, Lena E....
Transplantation and Cellular Therapy. 29 (2023) 2 - p. S205-S206 , 2023

Link: https://doi.org/10.1016/..

10

Tisagenlecleucel utilisation and outcomes across refractory..:

Barsan, Valentin ; Li, Yimei ; Prabhu, Snehit...
eClinicalMedicine. 65 (2023) - p. 102268 , 2023

Link: https://doi.org/10.1016/..

11

Rare tumors: Opportunities and challenges from the Children..:

Schultz, Kris Ann P. ; Chintagumpala, Murali ; Piao, Jin...
EJC Paediatric Oncology. 2 (2023) - p. 100024 , 2023

Link: https://doi.org/10.1016/..

12

Non-viral nitric oxide-based gene therapy improves perfusio..:

Bellary, Aditi ; Nowak, Chance ; Iwanicki, Isabella...
Theranostics. 13 (2023) 10 - p. 3402-3418 , 2023

Link: https://doi.org/10.7150/..

13

Preinfusion factors impacting relapse immunophenotype follo..:

Lamble, Adam J. ; Myers, Regina M. ; Taraseviciute, Agne...
Blood Advances. 7 (2023) 4 - p. 575-585 , 2023

Link: https://doi.org/10.1182/..

14

Children's Oncology Group's 2023 blueprint for research: Ra..:

Schultz, Kris Ann P. ; Chintagumpala, Murali ; Piao, Jin...
Pediatric Blood & Cancer. 70 (2023) S6 - p. , 2023

Link: https://doi.org/10.1002/..

15

The clinical aspect of NTRK-fusions in pediatric papillary ..:

Ricarte-Filho, Julio C. ; Halada, Stephen ; O'Neill, Alison...
Cancer Genetics. 262-263 (2022) - p. 57-63 , 2022

Link: https://doi.org/10.1016/..